Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

Tonix Pharmaceuticals is also enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).

News / Press Releases
: News / Press Releases

News / Press Releases

Latest News

Tonix Pharmaceuticals to Present at 12th Annual LD Micro Main Event

Read Press Release

Upcoming Event

12th Annual LD Micro Main Event

Luxe Sunset Boulevard Hotel, Bel-Air, CA

Webcast

Upcoming Event

Special Meeting of the Shareholders

New York, NY

View Events